Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Assessment of Valproate on Ethanol Withdrawal

NCT03235531 is registered in ClinicalTrials.gov with CAMC Health System as lead sponsor.

NCT NCT03235531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03235531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Assessment of Valproate on Ethanol Withdrawal
Lead sponsor
CAMC Health System
Phase
Phase 4
Overall status
Terminated
Start date
July 11, 2017
Completion date
June 25, 2019
Enrollment
3 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence, alcohol use disorder, alcohol withdrawal syndrome, heavy drinking, trauma